Glucocorticoids in T cell development and function

Annual Review of Immunology

Volumn 18, Issue , 2000, Pages 309-345

  Ashwell, Jonathan D ^a   Lu, Frank W M ^a   Vacchio, Melanie S ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Apoptosis; Immunosuppression; T cell activation; Thymocyte selection

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; FAS LIGAND; GENE PRODUCT; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; T LYMPHOCYTE RECEPTOR;

APOPTOSIS; CELL NUCLEUS; CELL SELECTION; HORMONE RECEPTOR INTERACTION; HUMAN; LYMPHOCYTE DIFFERENTIATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; THYMOCYTE; TISSUE SPECIFICITY; TRANSCRIPTION REGULATION;

ANIMALS; APOPTOSIS; CELL DIVISION; GLUCOCORTICOIDS; HUMANS; RECEPTORS, GLUCOCORTICOID; T-LYMPHOCYTES; THYMUS GLAND;

EID: 0034049874     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.immunol.18.1.309     Document Type: Review

References (220)

1. Mintami F, Shimizu T, Ueno R, Ishimura Y, Izumi S, Komatsu N, Watanabe K. 1982. Cytochrome P450-11β and P450scc in adrenal cortex: zonal distribution and intramitochondrial localization by the horseradish peroxidase-labeled antibody method. J. Histochem. Cytochem. 30:1066-74
2. Geuze HJ, Slot JW, Yanagibashi K, McCracken JA, Schwartz AL, Hall PF. 1987. Immunogold cytochemistry of cytochromes P-450 in porcine adrenal cortex. Histochemistry 86:551-57
3. Payne AH. 1990. Hormonal regulation of cytochrome P450 enzymes, cholesterol side-chain cleavage and 17α-hydroxylase/C17-20 lyase in Leydig cells. Biol. Reprod. 42:399-404
4. LeGoascogne C, Robel P, Gouezou M, Sananes N, Baulieu EE, Waterman M. 1987. Neurosteroids: cytochrome P-450scc in rat brain. Science 237:1212-15
5. Vacchio MS, Papadopoulos V, Ashwell JD. 1994. Steroid production in the thymus: implications for thymocyte selection. J. Exp. Med. 179:1835-46
6. Keeney DS, Jenkins CM, Waterman MR. 1995. Developmentally regulated expression of adrenal 17 alpha-hydroxylase cytochrome P450 in the mouse embryo. Endocrinology 136:4872-79
7. Meikle AW, Tyler FH. 1977. Potency and duration of action of glucocorticoids. Effects of hydrocortisone, prednisone and dexamethasone on human pituitary-adrenal function. Am. J. Med. 63:200-7
8. Vinson GP, Whitehouse B, Hinson J. 1992. The Adrenal Cortex. Englewood Cliffs, NJ: Prentice-Hall
9. Simpson ER, Waterman MR. 1988. Regulation of the synthesis of steroidogenic enzymes in adrenal cortical cells by ACTH. Annu. Rev. Physiol. 50:427-40
10. Vinson GP, Whitehouse BJ, Hinson JP. 1998. Structure and function of the adrenal cortex. In Clinical Endocrinology, ed. A Grossman, p. 395. London: Blackwell Sci.
11. Jones MT, Gillham B. 1988. Factors involved in the regulation of adrenocorticotropic hormone/β-lipotropic hormone. Physiol. Rev. 68:743-818
12. Beato M, Herrlich P, Schutz G. 1995. Steroid hormone receptors: many actors in search of a plot. Cell 83:851-57
13. Owens-Grillo JK, Hoffmann K, Hutchison KA, Yem AW, Deibel MR Jr, Handschumacher RE, Pratt WB. 1995. The cyclosporin A-binding immunophilin CyP-40 and the FK506-binding immunophilin hsp56 bind to a common site on hsp90 and exist in independent cytosolic heterocomplexes with the untransformed glucocorticoid receptor. J. Biol. Chem. 270:20479-84
14. Abraham N, Miceli MC, Parnes JR, Veillette A, Abbot S. 1991. Enhancement of T-cell responsiveness by the lymphocyte-specific tyrosine protein kinase p56lck. Nature 350:62-66
15. Beato M. 1991. Transcriptional control by nuclear receptors. FASEB J. 5:2044-51
16. Zhang G, Zhang L, Duff GW. 1997. A negative regulatory region containing a glucocorticosteroid response element (nGRE) in the human interleukin-1β gene. DNA Cell Biol. 16:145-52
17. Diamond MI, Miner JN, Yoshinaga SK, Yamamoto KR. 1990. Transcription factor interactions: selectors of positive or negative regulation from a single DNA element. Science 249:1266-72
18. Shibata H, Spencer TE, Onate SA, Jenster G, Tsai SY, Tsai MJ, O'Malley BW. 1997. Role of co-activators and co-repressors in the mechanism of steroid/thyroid receptor action. Recent Prog. Horm. Res. 52:141-64
19. Bannister AJ, Kouzarides T. 1996. The CBP co-activator is a histone acetyltransferase. Nature 384:641-43
20. Chen H, Lin RJ, Schiltz RL, Chakravarti D, Nash A, Nagy L, Privalsky ML, Nakatani Y, Evans RM. 1997. Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell 90:569-80
21. Ogryzko VV, Schiltz RL, Russanova V, Howard BH, Nakatani Y. 1996. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87:953-59
22. Spencer TE, Jenster G, Burcin MM, Allis CD, Zhou J, Mizzen CA, McKenna NJ, Onate SA, Tsai SY, Tsai MJ, O'Malley BW. 1997. Steroid receptor coactivator-1 is a histone acetyltransferase. Nature 389:194-98
23. Yang XJ, Ogryzko VV, Nishikawa J, Howard BH, Nakatani Y. 1996. A p300/ CBP-associated factor that competes with the adenoviral oncoprotein EIA. Nature 382:319-24
24. Wade PA, Pruss D, Wolffe AP. 1997. Histone acetylation: chromatin in action. Trends Biochem. Sci. 22:128-32
25. Bodwell JE, Orti E, Coull JM, Pappin DJ, Smith LI, Swift F. 1991. Identification of phosphorylated sites in the mouse glucocorticoid receptor. J. Biol. Chem. 266:7549-55
26. Bodwell JE, Webster JC, Jewell CM, Cidlowski JA, Hu JM, Munck A. 1998. Glucocorticoid receptor phosphorylation: overview, function and cell cycle-dependence. J. Steroid Biochem. Mol. Biol. 65:91-99
27. Krstic MD, Rogatsky I, Yamamoto KR, Garabedian MJ. 1997. Mitogen-activated and cyclin-dependent protein kinases selectively and differentially modulate transcriptional enhancement by the glucocorticoid receptor. Mol. Cell. Biol. 17:3947-54
28. Weigel NL. 1996. Steroid hormone receptors and their regulation by phosphorylation. Biochem. J. 319:657-67
29. Mason SA, Housley PR. 1993. Site-directed mutagenesis of the phosphorylation sites in the mouse glucocorticoid receptor. J. Biol. Chem. 268:21501-4
30. Almlof T, Wright AP, Gustafsson JA. 1995. Role of acidic and phosphorylated residues in gene activation by the glucocorticoid receptor. J. Biol. Chem. 270:17535-40
31. Jewell CM, Webster JC, Burnstein KL, Sar M, Bodwell JE, Cidlowski JA. 1995. Immunocytochemical analysis of hormone mediated nuclear translocation of wild type and mutant glucocorticoid receptors. J. Steroid Biochem. Mol. Biol. 55:135-46
32. Webster JC, Jewell CM, Bodwell JE, Munck A, Sar M, Cidlowski JA. 1997. Mouse glucocorticoid receptor phosphorylation status influences multiple functions of the receptor protein. J. Biol. Chem. 272:9287-93
33. Bamberger CM, Bamberger AM, de Castro M, Chrousos GP. 1995. Glucocorticoid receptor β, a potential endogenous inhibitor of glucocorticoid action in humans. J. Clin. Invest. 95:2435-41
34. Oakley RH, Sar M, Cidlowski JA. 1996. The human glucocorticoid receptor β isoform. Expression, biochemical properties, and putative function. J. Biol. Chem. 271:9550-59
35. Leung DYM, Hamid Q, Vottero A, Szefler SJ, Surs W, Minshall E, Chrousos GP, Klemm DJ. 1997. Association of glucocorticoid insensitivity with increased expression of glucocorticoid receptor β. J. Exp. Med. 186:1567-74
36. Schüle R, Rangarajan P, Kliewer S, Ransone LJ, Bolado J, Yang N, Verma IM, Evans RM. 1990. Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor. Cell 62:1217-26
37. Yang-Yen HF, Chambard JC, Sun YL, Smeal T, Schmidt TJ, Drouin J, Karin M. 1990. Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction. Cell 62:1205-15
38. Jonat C, Rahmsdorf HJ, Park K-K, Cato ACB, Gebel S, Ponta H, Herrlich P. 1990. Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell 62:1189-204
39. Zacharchuk CM, Ashwell JD. 1992. Fruitful outcomes of intracellular cross-talk. Curr. Biol. 2:246-48
40. Gottlicher M, Heck S, Herrlich P. 1998. Transcriptional cross-talk, the second mode of steroid hormone receptor action. J. Mol. Med. 76:480-89
41. Stein B, Baldwin ASJ, Ballard DW, Greene WC, Angel P, Herrlich P. 1993. Cross-coupling of the NF-κB p65 and Fos/Jun transcription factors produces potentiated biological function. EMBO J. 12:3879-91
42. Ray A, Prefontaine KE. 1994. Physical association and functional antagonism between the p65 subunit of transcription factor NF-κB and the glucocorticoid receptor. Proc. Natl. Acad. Sci. USA 91:752-56
43. Caldenhoven E, Liden J, Wissink S, Van de Stolpe A, Raaijmakers J, Koenderman L, Okret S, Gustafsson JA, Van der Saag PT. 1995. Negative cross-talk between ReIA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids. Mol. Endocrinol. 9:401-12
44. Scheinman RI, Gualberto A, Jewell CM, Cidlowski JA, Baldwin AS Jr. 1995. Characterization of mechanisms involved in transrepression of NF-κB by activated glucocorticoid receptors. Mol. Cell. Biol. 15:943-53
45. Imai E, Miner JN, Mitchell JA, Yamamoto KR, Granner DK. 1993. Glucocorticoid receptor-cAMP response element-binding protein interaction and the response of the phosphoenolpyruvate carboxykinase gene to glucocorticoids. J. Biol. Chem. 268:5353-56
46. Zhang Z, Jones S, Hagod JS, Fuentes NL, Fuller GM. 1997. STAT3 acts as a coactivator of glucocorticoid receptor singaling. J. Biol. Chem. 272:30607-10
47. Stocklin E, Wissler M, Gouilleux F, Groner B. 1996. Functional interactions between StatS and the glucocorticoid receptor. Nature 383:726-28
48. Auphan N, Didonata JA, Rosette C, Hemberg A, Karin M. 1995. Immunosuppression by glucocorticoids: inhibition of NF-κB activity through induction of IκB synthesis. Science 270:286-90
49. Scheinman RI, Cogswell PC, Lofquist AK, Baldwin AS Jr. 1995. Role of transcriptional activation of IκBα in mediation of immunosuppression by glucocorticoids. Science 270:283-86
50. Brostjan C, Anrather J, Csizmadia V, Stroka D, Soares M, Bach FH, Winkler H. 1996. Glucocorticoid-mediated repression of NFκB activity in endothelial cells does not involve induction of IκBα synthesis. J. Biol. Chem. 271: 19612-16
51. Heck S, Bender K, Kullmann M, Gottlicher M, Herrlich P, Cato AC. 1997. IκBα-independent downregulation of NF-κB activity by glucocorticoid receptor. EMBO J. 16:4698-707
52. De Bosscher K, Schmitz ML, Vanden Berghe W, Plaisance S, Fiers W, Haegeman G. 1997. Glucocorticoid-mediated repression of nuclear factor-κB-dependent transcription involves direct interference with transactivation. Proc. Natl. Acad. Sci. USA 94:13504-9
53. Wissink S, van Heerde EC, vand der Burg B, van der Saag PT. 1998. A dual mechanism mediates repression of NF-κB activity by glucocorticoids. Mol. Endocrinol. 12:355-63
54. Star P. 1895. An unusual case of Addison's disease; sudden death; remarks. Lancet 1:284
55. Boinet E. 1899. Recherches expérimetales sur les fonctions des capsules surrénales. C.R. Seances Soc. Biol. Fil. 51:671-74
56. Jaffe HL. 1924. The influence of the supradrenal gland on the thymus. I. Regeneration of the thymus following double supradrenalectomy in the rat. J. Exp. Med. 40:325-41
57. Jaffe HL. 1924. The influence of the suprarenal gland on the thymus. III. Stimulation of the growth of the thymus gland following double supradrenalectomy in young rats. J. Exp. Med. 40:753-59
58. Selye H. 1936. Thymus and adrenals in the response of the organism to injuries and intoxication. Br. J. Exp. Pathol. 17:234-48
59. Dougherty TF, White A. 1943. Effect of pituitary adrenotropic hormone on lymphoid tissue. Proc. Soc. Exp. Biol. Med. 53:132-33
60. Heilman FR, Kendall EC. 1944. The influence of 11-dehydro-17-hydroxycorticosterone (compound E) on the growth of a malignant tumor in the mouse. Endocrinology 34:416-20
61. Mitchell IJ, Cooper AJ, Griffiths MR, Barber DJ. 1998. Phencyclidine and corticosteroids induce apoptosis of a subpopulation of striatal neurons: a neural substrate for psychosis? Neuroscience 84:489-501
62. Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC. 1998. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J. Clin. Invest. 102:274-82
63. Brokaw JJ, White GW, Baluk P, Anderson GP, Umemoto EY, McDonald DM. 1998. Glucocorticoid-induced apoptosis of dendritic cells in the rat tracheal mucosa. Am. J. Respir. Cell Mol. Biol. 19:598-605
64. Sentman CL, Shutter JR, Hockenbery D, Kanagawa O, Korsmeyer SJ. 1991. bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell 67:879-88
65. Siegel RM, Katsumata M, Miyashita T, Louie DC, Greene MI, Reed JC. 1992. Inhibition of thymocyte apoptosis and negative antigenic selection in bcl-2 transgenic mice. Proc. Natl. Acad. Sci. USA 89:7003-7
66. Grillot DA, Merino R, Nunez G. 1995. Bcl-XL displays restricted distribution during T cell development and inhibits multiple forms of apoptosis but not clonal deletion in transgenic mice. J. Exp. Med. 182:1973-83
67. Yoshida H, Kong YY, Yoshida R, Elia AJ, Hakem A, Hakem R, Penninger JM, Mak TW. 1998. Apaf1 is required for mitochondrial pathways of apoptosis and brain development. Cell 94:739-50
68. Hakem R, Hakem A, Duncan G. S, Henderson JT, Woo M, Soengas MS, Elia A, de la Pompa JL, Kagi D, Khoo W, Potter J, Yoshida R, Kaufman SA, Lowe SW, Penninger JM, Mak TW. 1998. Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell 94:339-52
69. Kuída K, Haydar TF, Kuan C. Y, Gu Y, Taya C, Karasuyama H, Su MS, Rakic P, Flavell RA. 1998. Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9. Cell 94:325-37
70. Stefanelli C, Bonavita F, Stanic {\hacek} I, Farruggia G, Falcieri E, Robuffo I, Pignatti C, Muscari C, Rossoni C, Guarnieri C, Caldarera CM. 1997. ATP depletion inhibits glucocorticoid-induced thymocyte apoptosis. Biochem. J. 322:909-17
71. Thomas N, Edwards JL, Bell PA. 1983. Studies of the mechanism of glucocorticoid-induced pyknosis in isolated rat thymocytes. J. Steroid Biochem. 18:519-24
72. Cohen JJ, Duke RC. 1984. Glucocorticoid activation of a calcium-dependent endonuclease in thymocyte nuclei leads to cell death. J. Immunol. 132:38-42
73. Perandones CE, Illera VA, Peckham D, Stunz LL, Ashman RF. 1993. Regulation of apoptosis in vitro in mature murine spleen T cells. J. Immunol. 151: 3521-29
74. Helmberg A, Auphan N, Caelles C, Karin M. 1995. Glucocorticoid-induced apoptosis of human leukemic cells is caused by the repressive function of the glucocorticoid receptor. EMBO J. 14:452-60
75. Reichardt HM, Kaestner K. H, Tuckermann J, Kretz O, Wessely O, Bock R, Gass P, Schmid W, Herrlich P, Angel P, Schutz G. 1998. DNA binding of the glucocorticoid receptor is not essential for survival. Cell 93:531-41
76. Harrigan MT, Baughman G, Campbell NF, Bourgeois S. 1989. Isolation and characterization of glucocorticoid-and cyclic AMP-induced genes in T lymphocytes. Mol. Cell. Biol. 9:3438-46
77. Baughman G, Harrigan MT, Campbell NF, Nurrish SJ, Bourgeois S. 1991. Genes newly identified as regulated by glucocorticoids in murine thymocytes. Mol. Endocrinol. 5:637-44
78. Baughman G, Lesley J, Trotter J, Hyman R, Bourgeois S. 1992. Tcl-30, a new T cell-specific gene expressed in immature glucocorticoid-sensitive thymocytes. J. Immunol. 149:1488-96
79. Owens GP, Hahn WE, Cohen JJ. 1991. Identification of mRNAs associated with programmed cell death in immature thymocytes. Mol. Cell. Biol. 11:4177-88
80. Goldstone SD, Lavin MF. 1991. Isolation of a cDNA clone, encoding a human β-galactoside binding protein, overexpressed during glucocorticoid-induced cell death. Biochem. Biophys. Res. Commun. 178:746-50
81. Memon SA, Petrak D, Moreno MB, Zacharchuk CM. 1995. A simple assay for examining the effect of transiently expressed genes on programmed cell death. J. Immunol. Methods 180:15-24
82. Deveraux QL, Takahashi R, Salvesen GS, Reed JC. 1997. X-linked IAP is a direct inhibitor of cell-death proteases. Nature 388:300-4
83. Duckett CS, Li F, Wang Y, Tomaselli KJ, Thompson CB, Armstrong RC. 1998. Human IAP-like protein regulates programmed cell death downstream of Bcl-xL and cytochrome c. Mol. Cell. Biol. 18:608-15
84. Deveraux QL, Roy N, Stennicke HR, Van Arsdale T, Zhou Q, Srinivasula SM, Alnemri ES, Salvesen GS, Reed JC. 1998. IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J. 17:2215-23
85. Roy N, Deveraux QL, Takahashi R, Salvesen GS, Reed JC. 1997. The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases. EMBO J. 16:6914-25
86. Robey E, Chang D, Itano A, Cado D, Alexander H, Lans D, Weinmaster G, Salmon P. 1996. An activated form of Notch influences the choice between CD4 and CD8 T cell lineages. Cell 87:483-92
87. Washburn T, Schweighoffer E, Gridley T, Chang D, Fowlkes BJ, Cado D, Robey E. 1997. Notch activity influences the αβ versus γδ T cell lineage decision. Cell 88:833-43
88. Hasserjian RP, Aster JC, Davi F, Weinberg DS, Sklar J. 1996. Modulated expression of notch1 during thymocyte development. Blood 88:970-76
89. Deftos ML, He YW, Ojala EW, Bevan MJ. 1998. Correlating notch signaling with thymocyte maturation. Immunity 9:777-86
90. Kullmann M, Schneikert J, Moll J, Heck S, Zeiner M, Gehring U, Cato AC. 1998. RAP46 is a negative regulator of glucocorticoid receptor action and hormoneinduced apoptosis. J. Biol. Chem. 273:14620-25
91. Grimm LM, Goldberg AL, Poirier GG, Schwartz LM, Osborne BA. 1996. Proteasomes play an essential role in thymocyte apoptosis. EMBO J. 15:3835-44
92. Zacharchuk CM, Mercep M, Chakraborti P, Simons SS Jr, Ashwell JD. 1990. Programmed T lymphocyte death: cell activation-and steroid-induced pathways are mutually antagonistic. J. Immunol. 145:4037-45
93. Iwata M, Hanaoka S, Sato K. 1991. Rescue of thymocytes and T cell hybridomas from glucocorticoid-induced apoptosis by stimulation via the T cell receptor/ CD3 complex: a possible in vitro model for positive selection of the T cell repertoire. Eur. J. Immunol. 21:643-48
94. Wagner DH Jr, Hagman J, Linsley PS, Hodsdon W, Freed JH, Newell MK. 1996. Rescue of thymocytes from glucocorticoid-induced cell death mediated by CD28/CTLA-4 costimulatory interactions with B7-1/B7-2. J. Exp. Med. 184:1631-38
95. Gruber J, Sgonc R, Hu YH, Beug H, Wick G. 1994. Thymocyte apoptosis induced by elevated endogenous corticosterone levels. Eur. J. Immunol. 24:1115-21
96. Ayala A, Herdon CD, Lehman DL, DeMaso CM, Ayala CA, Chaudry IH. 1995. The induction of accelerated thymic programmed cell death during polymicrobial sepsis: control by corticosteroids but not tumor necrosis factor. Shock 3:259-67
97. Tarcic N, Ovadia H, Weiss DW, Weidenfeld J. 1998. Restraint stress-induced thymic involution and cell apoptosis are dependent on endogenous glucocorticoids. J. Neuroimmunol. 82:40-46
98. Hockenbery DM, Zutter M, Hickey W, Nahm M, Korsmeyer SJ. 1991. BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc. Natl. Acad. Sci. USA 88:6961-65
99. Nakayama K, Nakayama K, Negishi I, Kuida K, Shinkai Y, Louie MC, Fields LE, Lucas PJ, Stewart V, Alt FW, Loh DY. 1993. Disappearance of the lymphoid system in Bcl-2 homozygous mutant chimeric mice. Science 261: 1584-88
100. Veis DJ, Sorenson CM, Shutter JR, Korsmeyer SJ. 1993. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 75:229-40
101. Henning SJ. 1978. Plasma concentrations of total and free corticosterone during development in the rat. Am. J. Physiol. 235:E451-56
102. Savu L, Zouaghi H, Nunez EA. 1985. Serum inflammatory responses of transcortin binding activities and of total and free corticosterone and progesterone levels in developing rats: a kinetic approach. Int. J. Tissue React. 7:443-48
103. Lanza L, Scudeletti M, Puppo F, Bosco O, Peirano L, Filaci G, Fecarotta E, Vidali G, Indiveri F. 1996. Prednisone increases apoptosis in in vitro activated human peripheral blood T lymphocytes. Clin. Exp. Immunol. 103:482-90
104. Horigome A, Hirano T, Oka K, Takeuchi H, Sakurai E, Kozaki K, Matsuno N, Nagao T, Kozaki M. 1997. Glucocorticoids and cyclosporine induce apoptosis in mitogen-activated human peripheral mononuclear cells. Immunopharmacology 37:87-94
105. Crabtree GR, Munck A, Smith KA. 1980. Glucocorticoids and lymphocytes. I. Increased glucocorticoid receptor levels in antigen-stimulated lymphocytes. J. Immunol. 124:2430-35
106. Clarke A. R, Purdie CA, Harrison DJ, Morris RG, Bird CC, Hooper ML, Wyllie AH. 1993. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362:849-52
107. Lowe SW, Schmitt E. M, Smith SW, Osborne BA, Jacks T. 1993. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362:847-49
108. Hench PS, Kendall EC, Slocumb CH, Polley HF. 1950. Effects of cortisone acetate and pituitary ACTH on rheumatoid arthritis, rheumatic fever and certain other conditions. Arch. Int. Med. 85:545-66
109. Plotz CM. 1975. Corticosteroids as immunosuppressive drugs: a brief perspective. Transplant. Proc. 7:5-6
110. Billingham RE, Krohn BA, Medawar PB. 1951. Effect of cortisone on survival of skin homografts in rabbits. Br. Med. J. 1:1157-63
111. Medawar PB, Sparrow EM. 1956. The effects of adrenocortical hormones, adrenocorticotrophic hormone and pregnancy on skin transplantation immunity in mice. J. Endocrinol. 14:240-56
112. Crabtree GR, Gillis S, Smith KA, Munck A. 1980. Mechanisms of glucocorticoid-induced immunosuppression: inhibitory effects on expression of Fc receptors and production of T-cell growth factor. J Steroid Biochem 12:445-49
113. Almawi WY, Beyhum HN, Rahme AA, Rieder MJ. 1996. Regulation of cytokine and cytokine receptor expression by glucocorticoids. J. Leukoc. Biol. 60:563-72
114. Kunicka JE, Talle MA, Denhardt GH, Brown M, Prince LA, Goldstein G. 1993. Immunosuppression by glucocorticoids: inhibition of production of multiple lymphokines by in vivo administration of dexamethasone. Cell. Immunol. 149:39-49
115. Fushimi T, Shimura S, Suzuki S, Saitoh H, Okayama H, Shirato K. 1998. Suppression of gene expression and production of interleukin 13 by dexamethasone in human peripheral blood mononuclear cells. Tohoku J. Exp. Med. 185:157-60
116. Rolfe FG, Hughes JM, Armour CL, Sewell WA. 1992. Inhibition of interleukin-5 gene expression by dexamethasone. Immunology 77:494-99
117. Northrop JP, Crabtree GR, Mattila PS. 1992. Negative regulation of interleukin 2 transcription by the glucocorticoid receptor. J. Exp. Med. 175:1235-45
118. Vacca A, Felli MP, Farina AR, Martinotti S, Maroder M, Screpanti I, Meco D, Petrangeli E, Frati L, Gulino A. 1992. Glucocorticoid receptor-mediated suppression of the interleukin 2 gene expression through impairment of the cooperativity between nuclear factor of activated T cells and AP-1 enhancer elements. J. Exp. Med. 175:637-46
119. Paliogianni F, Raptis A, Ahuja SS, Najjar SM, Boumpas DT. 1993. Negative transcriptional regulation of human interleukin 2 (IL-2) gene by glucocorticoids through interference with nuclear transcription factors AP-1 and NF-ATJ. Clin. Invest. 91:1481-89
120. Granelli-Piperno A, Nolan P, Inaba K, Steinman RM. 1990. The effect of immunosuppressive agents on the induction of nuclear factors that bind to sites on the interleukin 2 promoter. J. Exp. Med. 172:1869-72
121. Adcock IM, Brown C. R, Gelder CM, Shirasaki H, Peters MJ, Barnes PJ. 1995. Effects of glucocorticoids on transcription factor activation in human peripheral blood mononuclear cells. Am. J. Physiol. 268:C331-38
122. Tobler A, Meier R, Seitz M, Dewald B, Baggiolini M, Fey MF. 1992. Glucocorticoids downregulate gene expression of GM-CSF, NAP-1/IL-8, and IL-6, but not of M-CSF in human fibroblasts. Blood 79:45-51
123. Re F, Muzio M, De Rossi M, Polentarutti N, Giri J. G, Mantovani A, Colotta F. 1994. The type II "receptor" as a decoy target for interleukin 1 in polymorphonuclear leukocytes: characterization of induction by dexamethasone and Iigand binding properties of the released decoy receptor. J. Exp. Med. 179:739-43
124. Levine SJ, Benfield T, Shelhamer JH. 1996. Corticosteroids induce intracellular interleukin-1 receptor antagonist type I expression by a human airway epithelial cell line. Am. J. Respir. Cell Mol. Biol. 15:245-51
125. Lamas M, Sanz E, Martin-Parras L, Espel E, Sperisen P, Collins M, Silva AG. 1993. Glucocorticoid hormones upregulate interleukin 2 receptor a gene expression. Cell. Immunol. 151:437-50
126. Fernandez-Ruiz E, Rebollo A, Nieto MA, Sanz E, Somoza C, Ramirez F, Lopez-Rivas A, Silva A. 1989. IL-2 protects T cell hybrids from the cytolytic effect of glucocorticoids. Synergistic effect of IL-2 and dexamethasone in the induction of high-affinity IL-2 receptors. J. Immunol. 143:4146-51
127. Wiegers GJ, Labeur MS, Stec IE, Klinkert WE, Holsboer F, Reul JM. 1995. Glucocorticoids accelerate anti-T cell receptor-induced T cell growth. J. Immunol. 155:1893-902
128. Boumpas DT, Anastassiou ED, Older SA, Tsokos GC, Nelson DL, Balow JE. 1991. Dexamethasone inhibits human interleukin 2 but not interleukin 2 receptor gene expression in vitro at the level of nuclear transcription. J. Clin. Invest. 87:1739-47
129. Batuman OA, Ferrero AP, Diaz A, Berger B, Pomerantz RJ. 1994. Glucocorticoidmediated inhibition of interleukin-2 receptor-α and -β subunit expression by human T cells. Immunopharmacology 27:43-55
130. Paliogianni F, Ahuja SS, Balow JP, Balow JE, Boumpas DT. 1993. Novel mechanism for inhibition of human T cells by glucocorticoids. Glucocorticoids inhibit signal transduction through IL-2 receptor. J. Immunol. 151:4081-89
131. Louahed J, Renauld JC, Demoulin JB, Baughman G, Bourgeois S, Sugamura K, Van Snick J. 1996. Differential activity of dexamethasone on IL-2-, IL-4-, or IL-9-induced proliferation of murine factor-dependent T cell lines. J. Immunol. 156:3704-10
132. Cronstein BN, Kimmel SC, Levin RI, Martiniuk F, Weissmann G. 1992. A mechanism for the antiinflammatory effects of corticosteroids: the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1. Proc. Natl. Acad. Sci. USA 89:9991-95
133. + lymphocytes. Cell. Immunol. 187:38-44
134. Wargnier A, Lafaurie C, Legros-Maida S, Bourge JF, Sigaux F, Sasportes M, Paul P. 1998. Down-regulation of human granzyme B expression by glucocorticoids. Dexamethasone inhibits binding to the ikaros and ap-1 regulatory elements of the granzyme b promoter. J. Biol. Chem. 273:35326-31
135. Baus E, Andris F, Dubois PM, Urbain J, Leo O. 1996. Dexamethasone inhibits the early steps of antigen receptor signaling in activated T lymphocytes. J. Immunol. 156:4555-61
136. Mosmann TR, Sad S. 1996. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today 17:138-46
137. Rissoan MC, Soumelis V, Kadowaki N, Grouard G, Briere F, de Waal Malefyt R, Liu YJ. 1999. Reciprocal control of T helper cell and dendritic cell differentiation. Science 283:1183-86
138. Daynes RA, Araneo BA. 1989. Contrasting effects of glucocorticoids on the capacity of T cells to produce the growth factors interleukin 2 and interleukin 4. Eur. J. Immunol. 19:2319-25
139. Sierra-Honigmann MR, Murphy PA. 1992. T cell receptor-independent immunosuppression induced by dexamethasone in murine T helper cells. J. Clin. Invest. 89:556-60
140. Bertoglio JH, Leroux E. 1988. Differential effects of glucocorticoids on the proliferation of a murine helper and a cytolytic T cell clone in response to IL-2 and IL-4. J. Immunol. 141:1191-96
141. + T cells in vitro. J. Immunol. 156:2406-12
142. Dozmorov IM, Miller RA. 1998. Generation of antigen-specific Th2 cells from unprimed mice in vitro: effects of dexamethasone and anti-IL-10 antibody. J. Immunol. 160:2700-5
143. Posey WC, Nelson HS, Branch B, Pearlman DS. 1978. The effects of acute corticosteroid therapy for asthma on serum immunoglobulin levels. J. Allergy Clin. Immunol. 62:340-48
144. Jabara HH, Ahern DJ, Vercelli D, Geha RS. 1991. Hydrocortisone and IL-4 induce IgE isotype switching in human B cells. J. Immunol. 147:1557-60
145. Wu CY, Sarfati M, Hausser C, Fournier S, Rubio-Trujillo M, Peleman R, Delespesse G. 1991. Glucocorticoids increase the synthesis of immunoglobulin E by interleukin 4-stimulated human lymphocytes. J. Clin. Invest. 87:870-77
146. Bohle B, Willheim M, Baier K, Stadler B, Spitzauer S, Scheiner O, Kraft D, Ebner C. 1995. Hydrocortisone enhances total IgE levels - but not the synthesis of allergen-specific IgE - in a monocytedependent manner. Clin. Exp. Immunol. 101:474-79
147. Wu CY, Fargeas C, Nakajima T, Delespesse G. 1991. Glucocorticoids suppress the production of interleukin 4 by human lymphocytes. Eur. J. Immunol. 21:2645-47
148. Wang Y, Campbell HD, Young IG. 1993. Sex hormones and dexamethasone modulate interleukin-5 gene expression in T lymphocytes. J. Steroid Biochem. Mol. Biol. 44:203-10
149. Franchimont D, Louis E, Dewe W, Martens H, Vrindts-Gevaert Y, De Groote D, Belaiche J, Geenen V. 1998. Effects of dexamethasone on the profile of cytokine secretion in human whole blood cell cultures. Regul. Pept. 73:59-65
150. Visser J, van Boxel-Dezaire A, Methorst D, Brunt T, de Kloet ER, Nagelkerken L. 1998. Differential regulation of interleukin-10 (IL-10) and IL-12 by glucocorticoids in vitro. Blood 91:4255-64
151. Ramirez F. 1998. Glucocorticoids induce a Th2 response in vitro. Dev. Immunol. 6:233-43
152. Ashwell JD, Cunningham RE, Noguchi PD, Hernandez D. 1987. Cell growth cycle block of T cell hybridomas upon activation with antigen. J. Exp. Med. 165:173-94
153. Mercep M, Bluestone JA, Noguchi PD, Ashwell JD. 1988. Inhibition of transformed T cell growth in vitro by monoclonal antibodies directed against distinct activating molecules. J. Immunol. 140:324-35
154. Ucker DS, Ashwell JD, Nickas G. 1989. Activation driven T cell death. I. Requirements for de novo transcription and translation and association with genome fragmentation. J. Immunol. 143:3461-69
155. Russell JH, White CL, Loh DY, Meleedy-Rey P. 1991. Receptor-stimulated death pathway is opened by antigen in mature T cells. Proc. Natl. Acad. Sci. USA 88:2151-55
156. Ucker DS, Meyers J, Obermiller PS. 1992. Activation-driven T cell death. II. Quantitative differences alone distinguish stimuli triggering nontransformed T cell proliferation or death. J. Immunol. 149:1583-92
157. Wesselborg S, Janssen O, Kabelitz D. 1993. Induction of activation-driven death (apoptosis) in activated but not resting peripheral blood T cells. J. Immunol. 150:4338-45
158. Dhein J, Walczak H, Bäumler C, Debatin K.-M, Krammer PH. 1995. Autocrine T-cell suicide mediated by APO-1/(Fas/ CD95). Nature 373:438-41
159. Brunner T, Mogil RJ, LaFace D, Yoo NJ, Mahboubi A, Echeverri F, Martin SJ, Force WR, Lynch DH, Ware CF, Green DR. 1995. Cell-autonomous Fas CD95 / Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373:441-44
160. Ju S-T, Panka DJ, Cui H, Ettinger R, ElKhatib M, Sherr DH, Stanger BZ, Marshak-Rothstein A. 1995. Fas(CD95)/ FasL interactions required for programmed cell death after T-cell activation. Nature 373:444-48
161. Yang Y, Mercep M, Ware CF, Ashwell JD. 1995. Fas and activation-induced Fas ligand mediate apoptosis of T cell hybridomas: inhibition of Fas ligand expression by retinoic acid and glucocorticoids. J. Exp. Med. 181:1673-82
162. D'Adamio F, Zollo O, Moraca R, Ayroldi E, Bruscoli S, Bartoli A, Cannarile L, Migliorati G, Riccardi C. 1997. A new dexamethasone-induced gene of the leucine zipper family protects T lymphocytes from TCR/CD3-activated cell death. Immunity 7:803-12
163. Latinis KM, Norian LA, Eliason SL, Koretzky GA. 1997. Two NFAT transcription factor binding sites participate in the regulation of CD95 (Fas) ligand expression in activated human T cells. J. Biol. Chem. 272:31427-34
164. Holtz-Heppelmann CJ, Algeciras A, Badley AD, Paya CV. 1998. Transcriptional regulation of the human FasL promoter-enhancer region. J. Biol. Chem. 273:4416-23
165. Mittelstadt PR, Ashwell JD. 1999. Role of Egr-2 in up-regulation of Fas ligand in normal T cells and aberrant double-negative lpr and gld T cells. J. Biol. Chem. 274:3222-27
166. Mittelstadt PR, Ashwell JD. 1998. The cyclosporin A-sensitive transcription factor Egr-3 regulates Fas ligand expression. Mol. Cell. Biol. 18:3744-51
167. Matsui K, Fine A, Zhu B, Marshak-Rothstein A, Ju ST. 1998. Identification of two NF-κB sites in mouse CD95 ligand (Fas ligand) promoter: functional analysis in T cell hybridoma. J. Immunol. 161:3469-73
168. Kasibhatla S, Genestier L, Green DR. 1999. Regulation of fas-ligand expression during activation-induced cell death in T lymphocytes via NF-κB. J. Biol. Chem. 274:987-92
169. Mages HW, Baag R, Steiner B, Kroczek RA. 1998. Utilization of an NF-ATp binding promoter element for EGR3 expression in T cells but not fibroblasts provides a molecular model for the lymphoid cell-specific effect of cyclosporin A. Mol. Cell. Biol. 18:7157-65
170. Rengarajan J, Mittelstadt PR, Mages H-W, Gerth A, Kroczek R, Ashwell JD, Glimcher LH. 1999. Sequential involvement of NFAT and Egr transcription factors in Th1-specific FasL regulation. Submitted.
171. Nocentini G, Giunchi L, Ronchetti S, Krausz LT, Bartoli A, Moraca R, Migliorati G, Riccardi C. 1997. A new member of the tumor necrosis factor/nerve growth factor receptor family inhibits T cell receptor-induced apoptosis. Proc. Natl. Acad. Sci. USA 94:6216-21
172. Gurney AL, Marsters SA, Huang RM, Pitti RM, Mark DT, Baldwin DT, Gray AM, Dowd AD, Brush AD, Heldens AD, Schow AD, Goddard AD, Wood WI, Baker KP, Godowski PJ, Ashkenazi A. 1999. Identification of a new member of the tumor necrosis factor family and its receptor, a human ortholog of mouse GITR. Curr. Biol. 9:215-18
173. Kwon B, Yu KY, Ni J, Yu GL, Jang IK, Kim YJ, Xing L, Liu D, Wang SX, Kwon BS. 1999. Identification of a novel activation-inducible protein of the tumor necrosis factor receptor superfamily and its ligand. J. Biol. Chem. 274:6056-61
174. Liu ZG, Smith SW, McLaughlin KA, Schwartz LM, Osborne BA. 1994. Apoptotic signals delivered through the T-cell receptor of a T-cell hybrid require the immediate-early gene nur77. Nature 367:281-84
175. Woronicz JD, Calnan B, Ngo V, Winoto A. 1994. Requirement for the orphan steroid receptor Nur77 in apoptosis of T-cell hybridomas. Nature 367:277-81
176. Weih F, Ryseck RP, Chen L, Bravo R. 1996. Apoptosis of nur77/N10-transgenic thymocytes involves the Fas/Fas ligand pathway. Proc. Natl. Acad. Sci. USA 93:5533-38
177. Philips A, Maira M, Mullick A, Chamberland M, Lesage S, Hugo P, Drouin J. 1997. Antagonism between Nur77 and glucocorticoid receptor for control of transcription. Mol. Cell. Biol. 17:5952-59
178. Philips A, Lesage S, Gingras R, Maira MH, Gauthier Y, Hugo P, Drouin J. 1997. Novel dimeric Nur77 signaling mechanism in endocrine and lymphoid cells. Mol. Cell. Biol. 17:5946-51
179. Pelfrey CM, Tranquill LR, Boehme SA, McFarland HF, Lenardo MJ. 1995. Two mechanisms of antigen-specific apoptosis of myelin basic protein (MBP)-specific T lymphocytes derived from multiple sclerosis patients and normal individuals. J. Immunol. 1548:6191-202
180. + T lymphocytes from activation-induced apoptosis triggered by HIV-1: implications for pathogenesis and therapy. AIDS 9:35-42
181. Bäumler CB, Böhler T, Herr I, Benner A, Krammer PH, Debatin K-M. 1996. Activation of the CD95 (APO-1/Fas) system in T cells from human immunodeficiency virus type-1-infected children. Blood 88:1741-46
182. Yang Y, Liu Z-H, Ware CF, Ashwell JD. 1997. A cysteine protease inhibitor prevents activation-induced T cell apoptosis and death of peripheral blood cells from HIV-infected individuals by inhibiting upregulation of Fas ligand. Blood 89:550-57
183. van Oers NS, von Boehmer H, Weiss A. 1995. The pre-T cell receptor (TCR) complex is functionally coupled to the TCR-ζ subunit. J. Exp. Med. 182:1585-90
184. Kisielow P, von Boehmer H. 1995. Development and selection of T cells: facts and puzzles. Adv. Immunol. 58:87-209
185. Huesmann M, Scott B, Kisielow P, von Boehmer H. 1991. Kinetics and efficacy of positive selection in the thymus of normal and T cell receptor transgenic mice. Cell 66:533-40
186. Singer GG, Abbas AK. 1994. The fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1:365-71
187. Page DM, Roberts EM, Peschon JJ, Hedrick SM. 1998. TNF receptor-deficient mice reveal striking differences between several models of thymocyte negative selection. J. Immunol. 160:120-33
188. Gravestein LA, Borst J. 1998. Tumor necrosis factor receptor family members in the immune system. Semin. Immunol. 10:423-34
189. Alberola-Ila J, Hogquist KA, Swan KA, Bevan MJ, Perlmutter RM. 1996. Positive and negative selection invoke distinct signaling pathways. J. Exp. Med. 184:9-18
190. O'Shea CC, Crompton T, Rosewell IR, Hayday AC, Owen MJ. 1996. Raf regulates positive selection. Eur. J. Immunol. 26:2350-55
191. Urdahl KB, Pardoll DM, Jenkins MK. 1994. Cyclosporin A inhibits positive selection and delays negative selection in αβ TCR transgenic mice. J. Immunol. 152:2853-59
192. Zacharchuk CM, Mercep, M, Ashwell, JD. 1991. Thymocyte activation and death: a mechanism for molding the T cell repertoire. In Antigen and Clone-Specific Immunoregulation, ed. RL Edelson, p. 52. New York: Ann. NY Acad. Sci.
193. Noel PJ, Boise LH, Green JM, Thompson CB. 1996. CD28 costimulation prevents cell death during primary T cell activation. J. Immunol. 157:636-42
194. Ballard PL. 1979. Glucocorticoids and differentiation. In Glucocorticoid Hormone Action, ed. JD Baxter, GG Rousseau, p. 493. Berlin: Springer-Verlag
195. Murphy BEP, Díez d'Aux RC. 1972. Steroid levels in the human fetus: cortisol and cortisone. J. Clin. Endocrinol. Metab. 35:678-83
196. Lechner O, Wiegers GJ, Oliveira-dos-Santos AJ, Dietrich H, Recheis H, Waterman M, Boyd R, Wick G. 1999. Glucocorticoid production in the murine thymus. Eur. J. Immunol. In press
197. Pazirandeh A, Xue Y, Rafter I, Sjovall J, Jondal M, Okret S. 1999. Paracrine glucocorticoid activity produced by mouse thymic epithelial cells. FASEB J. 13: 893-901
198. Kisielow P, Teh HS, Blüthmann H, von Boehmer H. 1988. Positive selection of antigen-specific T cells in thymus by restricting MHC molecules. Nature 335:730-33
199. Teh HS, Kisielow P, Scott B, Kishi H, Uematsu Y, Blüthmann H, von Boehmer H. 1988. Thymic major histocompatibility complex antigens and the αβ T-cell receptor determine the CD4/CD8 phenotype of T cells. Nature 335:229-33
200. Vacchio MS, Ashwell JD. 1997. Thymus-derived glucocorticoids regulate antigen-specific positive selection. J. Exp. Med. 185:2033-38
201. Sacedon R, Varas A, Jimenez E, Munoz JJ, Vicente A, Zapata AG. 1999. Accelerated maturation of the thymic stroma in the progeny of adrenalectomized pregnant rats. Neuroimmunomodulation 6:23-30
202. Garvin AM, Abraham KM, Forbush KA, Farr AG, Davison BL, Perlmutter RM. 1990. Disruption of thymocyte development and lymphomagenesis induced by SV40 T-antigen. Int. Immunol. 2:173-80
203. King LB, Vacchio MS, Dixon K, Hunziker R, Margulies DH, Ashwell JD. 1995. A targeted glucocorticoid receptor antisense transgene increases thymocyte apoptosis and alters thymocyte development. Immunity 3:647-56
204. Pepin MC, Pothier F, Barden N. 1992. Impaired type II glucocorticoid-receptor function in mice bearing antisense RNA transgene. Nature 355:725-28
205. Morale MC, Batticane N, Gallo F, Barden N, Marchetti B. 1995. Disruption of hypothalamic-pituitary-adrenocortical system in transgenic mice expressing type II glucocorticoid receptor antisense ribonucleic acid permanently impairs T cell function: effects on T cell trafficking and T cell responsiveness during post-natal development. Endocrinology 136: 3949-60
206. Vacchio MS, Lee JYM, Ashwell JD. 1999. Thymus-derived glucocorticoids set the thresholds for thymocyte selection by inhibiting TCR-mediated thymocyte activation. J. Immunol. 163:1327-33
207. Shortman K, Egerton M, Spangrude GJ, Scollay R. 1990. The generation and fate of thymocytes. Semin. Immunol. 2:3-12
208. Zerrahn J, Held W, Raulet DH. 1997. The MHC reactivity of the T cell repertoire prior to positive and negative selection. Cell 88:627-36
209. Merkenschlager M, Graf D, Lovatt M, Bommhardt U, Zamoyska R, Fisher AG. 1997. How many thymocytes audition for selection? J. Exp. Med. 186:1149-58
210. Vidovic D, Boulanger N, Kuye O, Toral J, Ito K, Guenot J, Bluethmann H, Nagy ZA. 1997. The helper T-cell repertoire of mice expressing class II major histocompatibility complex β chains in the absence of a chains. Immunogenetics 45:325-35
211. + thymocyte development defined by the lack of coreceptor binding in positive selection. J. Immunol. 154: 2588-99
212. Tolosa E, King LB, Ashwell JD. 1998. Thymocyte glucocorticoid resistance alters positive selection and inhibits autoimmunity and lymphoproliferative disease in MRL-lpr/lpr mice. Immunity 8:67-76
213. + T cells in lpr/lpr mice. J. Exp. Med. 172:1805-17
214. Perkins DL, Listman JA, Marshak-Rothstein A, Kozlow W, Kelley VR, Finn PW, Rimm IJ. 1996. Restriction of the TCR repertoire inhibits the development of memory T cells and prevents autoimmunity in lpr mice. J. Immunol. 156:4961-68
215. Peng SL, Fatenejad S, Craft J. 1996. Induction of nonpathologic, humoral autoimmunity in lupus-prone mice by a class II-restricted, transgenic αβ T cell. Separation of autoantigen-specific and -nonspecific help. J. Immunol. 157: 5225-30
216. Davis MM, McHeyzer-Williams M, Chien YH. 1995. T-cell receptor V-region usage and antigen specificity. The cytochrome c model system. Ann. NY Acad. Sci. 756:1-11
217. Lechner O, Hu Y, Jafarian-Tehrani M, Dietrich H, Schwarz S, Herold M, Haour F, Wick G. 1996. Disturbed immunoendocrine communication via the hypothalamo-pituitary-adrenal axis in murine lupus. Brain Behav. Immun. 10:337-50
218. Wick G, Sgonc R, Lechner O. 1998. Neuroendocrine-immune disturbances in animal models with spontaneous autoimmune diseases. Ann. NY Acad. Sci. 840:591-98
219. Michelson D, Stone L, Galliven E, Magiakou MA, Chrousos GP, Sternberg EM, Gold PW. 1994. Multiple sclerosis is associated with alterations in hypothalamic-pituitary-adrenal axis function. J. Clin. Endocrinol. Metab. 79:848-83
220. Cole TJ, Blendy JA, Monaghan AP, Krieglstein K, Schmid W, Aguzzi A, Fantuzzi G, Hummler E, Unsicker K, Schütz G. 1995. Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation. Genes Dev. 9:1608-21